Akutes Nierenversagen bei COVID-19

Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L et al (2020) Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 97(5):829–838

Cheng Y, Luo R, Wang X, Wang K, Zhang N, Zhang M et al (2020) The incidence, risk factors, and prognosis of acute kidney injury in adult patients with coronavirus disease 2019. Clin J Am Soc Nephrol 15(10):1394–1402

Gross O, Moerer O, Weber M, Huber T, Scheithauer S (2020) COVID-19-associated nephritis: early warning for disease severity and complications? Lancet 395(e10236):e87–e88

Pei G, Zhang Z, Peng J, Liu L, Zhang C, Yu C et al (2020) Renal involvement and early prognosis in patients with COVID-19 pneumonia. J Am Soc Nephrol 31(6):1157–1165

Hirsch J, Ng J, Ross D, Sharma P, Shah H, Barnett R et al (2020) Acute kidney injury in patients hospitalized with COVID-19. Kidney Int 98(1):209–218

Kellum J, van Till J, Mulligan G (2020) Targeting acute kidney injury in COVID-19. Nephrol Dial Transplant 35(10):1652–1662

Bellomo R, Kellum J, Ronco C, Wald R, Martensson J, Maiden M et al (2017) Acute kidney injury in sepsis. Intensive Care Med 43(6):816–828

Chan L, Chaudhary K, Saha A, Chauhan K, Vaid A, Baweja M et al (2020) Acute kidney injury in hospitalized patients with Covid-19. medRxiv. https://doi.org/10.1101/2020.05.04.20090944

Rubin S, Orieux A, Prevel R, Garric A, Bats M, Dabernat S et al (2020) Characterization of acute kidney injury in critically ill patients with severe coronavirus disease 2019. Clin Kidney J 13(3):354–361

Karagiannidis C, Mostert C, Hentschker C, Voshaar T, Malzahn J, Schillinger G et al (2020) Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med 8(9):853–862

Nadim M, Forni L, Mehta R, Connor M Jr, Liu K, Ostermann M et al (2020) COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) workgroup. Nat Rev Nephrol. https://doi.org/10.1038/s41581-020-00356-5

Ronco C, Reis T, Husain-Syed F (2020) Management of acute kidney injury in patients with COVID-19. Lancet Respir Med 8:738–742

Risitano A, Mastellos D, Huber-Lang M, Yancopoulou D, Garlanda C, Ciceri F et al (2020) Complement as a target in COVID-19? Nat Rev Immunol 20(6):343–344

Mohamed M, Lukitsch I, Torres-Ortiz AE, Walker J, Varghese V, Hernandez-Arroyo C et al (2020) Acute kidney injury associated with coronavirus disease 2019 in urban New Orleans. Kidney 1(7):614–622

Remmelink M, De Mendonca R, D’Haene N, De Clercq S, Verocq C, Lebrun L et al (2020) Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients. Crit Care 24(1):495

Menter T, Haslbauer J, Nienhold R, Savic S, Hopfer H, Deigendesch N et al (2020) Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and veriegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology 77(2):198–209

Chen T, Wu D, Chen H, Yan W, Yang D, Chen G et al (2020) Clinical characteristics of 113 deceased patients with coronarvirus disease 2019: retrospective study. BMJ 368:m1295

Martinez-Rojas M, Vega-Vega O, Bobadilla N (2020) Is the kidney a target of SARS-CoV-2? Am J Physiol Renal Physiol 318(6):F1454–F1462

Puelles V, Lütgehetmann M, Lindenmeyer M, Sperhake J, Wong M, Allweiss L et al (2020) Multiorgan and renal tropism of SARS-CoV‑2. N Engl J Med 383(6):590–592

Wan Y, Shang J, Graham R, Baric R, Li F (2020) Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol 94(7):e127

Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S et al (2020) SARS-CoV‑2 cell entry depends on ACE2 and TMPRSS2 and is blocked by clinically proven protease inhibitor. Cell 181(2):271–280

Yan R, Zhang Y, Li Y, XIa L, Guo Y, Zhou Q (2020) Structural basis for the recognition of SARS-CoV‑2 by full-length human ACE2. Science 367(6485):1444–1448

Su H, Yang M, Wan C, Yi L, Tang F (2020) HY Z, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 98(1):219–227

Braun F, Lütgehetmann M, Pfefferle S, Wong M, Carsten A, Lindenmeyer M et al (2020) SARS-CoV‑2 renal tropism associates with acute kidney inury. Lancet 396(10251):597–598

Remuzzi A, Remuzzi G (2020) COVID-19 and Italy: what next? Lancet 395(10231):1225–1228

Ishiyama Y, Gallagher P, Averill D, Trallant E, Brosnihan K, Ferrario C (2004) Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension 43(5):970–976

Wysocki J, Lores E, Ye M, Soler M, Batlle D (2020) Kidney and lung ACE2 expression after an ACE inhibitor or an ANG II receptor blocker: implications for COVID-19. J Am Soc Nephrol 31(9):1941–1943

Danser A, Epstein M, Batlle D (2020) Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers. Hypertension 75(6):1382–1385

Sparks M, South A, Welling P, Luther J, Cohen J, Byrd J et al (2020) Sound scinece before quick judgement regarding RAS blockade in COVID-19. Clin J Am Soc Nephrol 15(5):714–716

Gupta A, Coca S, Chan L, Melamed M, Brenner S, Hayek S et al (2020) AKI treated with renal replacement therapy in critically ill patients with COVID-19. J Am Soc Nephrol. https://doi.org/10.1681/ASN.2020060897